Brunen, Diede <br/><br/>
Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling.  [electronic resource] 

 -  Oncotarget  Jun 2016 
 - 37407-37419 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.9822  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Humans<br/>K562 Cells<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Mice<br/>Mice, Transgenic<br/>Mitogen-Activated Protein Kinase 14--antagonists & inhibitors<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-pim-1--antagonists & inhibitors<br/>Signal Transduction<br/>TOR Serine-Threonine Kinases--metabolism<br/>Xenograft Model Antitumor Assays